Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2014

01-01-2014 | Erratum

Erratum to: Initial development of the Symptom Screening in Pediatrics Tool (SSPedi)

Authors: Deborah Tomlinson, L. Lee Dupuis, Paul Gibson, Donna L. Johnston, Carol Portwine, Christina Baggott, Sue Zupanec, Julie Watson, Brenda Spiegler, Susan Kuczynski, Gail Macartney, Lillian Sung

Published in: Supportive Care in Cancer | Issue 1/2014

Login to get access

Excerpt

Erratum to: Support Care Cancer …
Metadata
Title
Erratum to: Initial development of the Symptom Screening in Pediatrics Tool (SSPedi)
Authors
Deborah Tomlinson
L. Lee Dupuis
Paul Gibson
Donna L. Johnston
Carol Portwine
Christina Baggott
Sue Zupanec
Julie Watson
Brenda Spiegler
Susan Kuczynski
Gail Macartney
Lillian Sung
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1974-5

Other articles of this Issue 1/2014

Supportive Care in Cancer 1/2014 Go to the issue

Original Article

Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial

Original Article

Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein

Original Article

The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Letter to the editor

Two-step method of major depression screening by patient health questionnaire for patients with lung cancer

Original Article

Agreement between telerehabilitation involving caregivers and face-to-face clinical assessment of lymphedema in breast cancer survivors

Original Article

Comparing two approaches for studying symptom clusters: factor analysis and structural equation modeling
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits